Pfizer CTI Call for Proposals
Boston Children’s Hospital and Pfizer Centers for Therapeutic Innovation (CTI) are requesting proposals for novel therapeutic targets with application across Pfizer’s core therapeutic areas. See the attached flyer for full information.
Areas of Interest:
- Oncology
- Internal Medicine
- Inflammation and Immunology
- Rare Disease
In Scope:
- Novel biological targets supported by:
- In-vivo and in-vitro models
- enabling genetics and mechanistic insights
- translational biochemical or cellular assay and biomarkers
- Modality agnostic (exception of cell-based therapies)
Out-of-Scope:
- Drug repurposing, standalone biomarker assays/platforms, medical devices, cell-based therapies
Submission Process:
- Develop a 2-3 page non-confidential document outlining the scientific background and research synopsis
- Pre-proposals should be reviewed by one of Pfizer’s Emerging Science Leads to determine suitability prior to submission, formal submission should be routed through TIDO
- Deadline- June 28, 2021